Arcutis Biotherapeutics Inc (ARQT) Insider Trading
- $26,587,659.55
- $24,981,711.37
- Dec. 31, 2024
- Todd Franklin Watanabe
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
July 18, 2022 | N/A | 6,000 | $24.40 | Sell | $146,400.00 | |
July 8, 2022 | Chief Technical Officer | 2,197 | $25.41 | Sell | $55,825.77 | |
July 8, 2022 | President and CEO | 1,500 | $25.00 | Sell | $37,500.00 | |
July 6, 2022 | CEO | 1,000 | $22.07 | Sell | $22,070.00 | |
June 24, 2022 | Major Shareholder | 341,971 | $21.31 | Sell | $7,287,402.01 | |
June 2, 2022 | SVP | 1,795 | $19.73 | Sell | $35,415.35 | |
June 1, 2022 | Director | 2,500 | $20.62 | Sell | $51,550.00 | |
May 5, 2022 | CEO | 1,000 | $21.76 | Sell | $21,760.00 | |
May 2, 2022 | Director | 2,500 | $20.44 | Sell | $51,100.00 | |
April 21, 2022 | Insider | 2,197 | $20.42 | Sell | $44,862.74 | |
April 8, 2022 | Major Shareholder | 200,000 | $20.71 | Sell | $4,142,000.00 | |
April 6, 2022 | Major Shareholder | 333,204 | $20.69 | Sell | $6,893,990.76 | |
April 5, 2022 | CEO | 1,000 | $21.43 | Sell | $21,430.00 | |
April 1, 2022 | Director | 7,500 | $20.02 | Sell | $150,150.00 | |
March 9, 2022 | CEO | 300 | $17.00 | Sell | $5,100.00 | |
March 7, 2022 | Insider | 30 | $16.44 | Sell | $493.20 | |
March 7, 2022 | CFO | 10 | $16.44 | Sell | $164.40 | |
March 7, 2022 | CEO | 770 | $17.05 | Sell | $13,128.50 | |
March 4, 2022 | SVP | 993 | $16.86 | Sell | $16,741.98 | |
March 4, 2022 | Insider | 981 | $16.86 | Sell | $16,539.66 | |
March 4, 2022 | CFO | 293 | $16.86 | Sell | $4,939.98 | |
March 4, 2022 | CEO | 2,489 | $16.86 | Sell | $41,964.54 | |
Feb. 9, 2022 | CEO | 1,000 | $17.00 | Sell | $17,000.00 | |
Jan. 5, 2022 | CEO | 1,000 | $21.59 | Sell | $21,590.00 | |
Jan. 3, 2022 | Director | 2,500 | $21.21 | Sell | $53,025.00 | |
Dec. 27, 2021 | CFO | 12,560 | $20.07 | Sell | $252,079.20 | |
Dec. 23, 2021 | Director | 2,500 | $20.16 | Sell | $50,400.00 | |
Dec. 8, 2021 | CEO | 1,000 | $17.00 | Sell | $17,000.00 | |
Nov. 5, 2021 | CEO | 1,000 | $21.50 | Sell | $21,500.00 | |
Nov. 1, 2021 | Director | 2,500 | $21.81 | Sell | $54,525.00 | |
Oct. 5, 2021 | CEO | 2,500 | $24.92 | Sell | $62,300.00 | |
Sept. 7, 2021 | CEO | 1,000 | $21.14 | Sell | $21,140.00 | |
Aug. 5, 2021 | CEO | 1,000 | $20.81 | Sell | $20,810.00 | |
July 6, 2021 | CEO | 1,750 | $26.58 | Sell | $46,515.00 | |
July 1, 2021 | Director | 2,200 | $26.13 | Sell | $57,486.00 | |
June 24, 2021 | Director | 729 | $27.50 | Sell | $20,047.50 | |
June 21, 2021 | Director | 2,516 | $27.50 | Sell | $69,190.00 | |
June 7, 2021 | CEO | 1,750 | $26.35 | Sell | $46,112.50 | |
May 7, 2021 | CEO | 750 | $35.00 | Sell | $26,250.00 | |
May 5, 2021 | CEO | 1,750 | $34.00 | Sell | $59,500.00 | |
April 20, 2021 | Director | 10,000 | $28.06 | Sell | $280,600.00 | |
April 5, 2021 | CEO | 1,750 | $29.93 | Sell | $52,377.50 | |
April 1, 2021 | Director | 2,200 | $29.49 | Sell | $64,878.00 | |
March 22, 2021 | Director | 10,000 | $31.10 | Sell | $311,000.00 | |
March 5, 2021 | CEO | 1,750 | $30.55 | Sell | $53,462.50 | |
Feb. 10, 2021 | CFO | 750 | $35.64 | Sell | $26,730.00 | |
Feb. 1, 2021 | Director | 9,949 | $33.25 | Sell | $330,804.25 | |
Feb. 1, 2021 | CFO | 1,250 | $35.00 | Sell | $43,750.00 | |
Jan. 29, 2021 | Director | 51 | $27.50 | Sell | $1,402.50 | |
Jan. 19, 2021 | CFO | 500 | $30.00 | Sell | $15,000.00 |
Insiders are both buying and selling Arcutis Biotherapeutics Inc stock.
The insider traders at Arcutis Biotherapeutics Inc are: Todd Franklin Watanabe, Howard G Welgus, Patrick Burnett, Masaru Matsuda, Bhaskar Chaudhuri, Scott L Burrows, John W. Smither, Patricia A Turney, Orbimed Advisors Llc, Larry Todd Edwards, Life Sciences Viii L Frazier, Howard G. Welgus, David W Osborne, Welgus Howard G., Terrie Curran, David Joseph Topper, Watanabe Todd Franklin, Jonathan Silverstein, David W. Osborne, and OSBORNE DAVID W
The most active insider trader at Arcutis Biotherapeutics Inc is Todd Franklin Watanabe with 29 trades.
Orbimed Advisors Llc has sold the most Arcutis Biotherapeutics Inc stock with a total value of $25,610,794.78.
Jonathan Silverstein has bought the most Arcutis Biotherapeutics Inc stock with a total value of $28,659,776.64.
The most recent insider trade for Arcutis Biotherapeutics Inc was on Dec. 31, 2024.
The single biggest insider buy for Arcutis Biotherapeutics Inc was from Jonathan Silverstein with a total value of $14,329,888.32 on Feb. 3, 2020.
The single biggest insider sell for Arcutis Biotherapeutics Inc was from Orbimed Advisors Llc with a total value of $7,287,402.01 on June 24, 2022.